Understanding Closing Remarks 2019 Cure Om Symposium
Exploring Closing Remarks 2019 Cure Om Symposium reveals several interesting facts. Lauren Johnston, MRF Program Officer for Rare Melanoma Subtypes, delivers
Key Takeaways about Closing Remarks 2019 Cure Om Symposium
- Richard Carvajal, MD, Marlana Orloff, MD and Jacqueline Kraska provide an update on the
- Dr. William Newsome, Harman Family Provostial Professor, Vincent V. C. Woo Director of the Wu Tsai Neurosciences Institute, ...
- Sara Selig, MD, MPH, Co-Founder and Director of the MRF's
- Jim Mills shares his experience and the powerful lessons he learned as an ocular melanoma caregiver.
- Marlana Orloff, MD and Richard Carvajal, MD participate in a panel discussion about ocular melanoma clinical trials.
Detailed Analysis of Closing Remarks 2019 Cure Om Symposium
The MRF's In the 3rd Asia-Pacific Cholangiocarcinoma
Kyleigh LiPira, MBA, CEO of the Melanoma Research Foundation, welcomes attendees to the
Stay tuned for more updates related to Closing Remarks 2019 Cure Om Symposium.